Original InvestigationPathogenesis and Treatment of Kidney DiseaseA 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
Keywords: Chronic kidney disease (CKD); iron-deficiency anemia; hemoglobin; transferrin saturation (TSAT); ferric citrate coordination complex (ferric citrate); oral iron therapy; phosphate binder; iron repletion; serum phosphate; urinary phosphate excretion; fibro